Prenetics Global Limited Class A Ordinary Share (PRE)
$16.39▼ −0.49%
Close Nov 3, 2026 · split-adjusted
Nov 3, 2026$16.39▲ 20.78% in range
Nov 3, 2025Low $11.79 · High $26.25Nov 3, 2026
What changed · written from our data
As of Nov 3, 2026
Prenetics Global Limited closed at $16.39 on Nov 3, down 0.49%, 37.6% below its 52-week closing high. Volume of 48.6K shares was 0.24× its 20-day average (below normal).
Split-adjusted performance: -21.8% over one month, -2.0% over six months, +10.6% over one year.
Short interest was 515.0K shares at the Oct 15 settlement, up 16.5% from the prior report (3.8% of float, 2.5 days to cover).
Prenetics Global Ltd is a consumer health and wellness company offering nutrition and longevity products through its flagship brand, IM8. It offers science-backed daily nutrition and longevity products distributed directly to consumers across multiple countries.
What is PRE's market cap?
$319.84M, based on the Nov 3 close of $16.39.
Does Prenetics Global Limited pay a dividend?
No regular cash dividend has been paid in the last year.
How much of PRE is sold short?
515.0K shares, 3.8% of float, as of Oct 15, 2026.
About Prenetics Global Limited
Prenetics Global Ltd is a consumer health and wellness company offering nutrition and longevity products through its flagship brand, IM8. It offers science-backed daily nutrition and longevity products distributed directly to consumers across multiple countries. The company's products are developed with scientific input and are subject to third-party quality certifications.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology